Advancing Plasma Collection for Life-Saving Therapies
Alpha-1 Plasma Holdings is a strategic holding company focused on building critical plasma collection infrastructure to support the growing demand for plasma-derived therapies. Through targeted acquisitions, operational excellence, innovative real estate development, and creative industry partnerships, we are developing a scalable, integrated platform to expand global plasma supply.
ABOUT US
Who We Are
Alpha-1 Plasma Holdings is a strategic holding company dedicated to expanding the global availability of human plasma for plasma-derived medicinal product (PDMP) manufacturers. We acquire, build, and operate plasma collection platforms in partnership with industry leaders. With a focus on innovation, operational execution, and real estate-driven growth, Alpha-1 is advancing the next generation of plasma infrastructure.
Strategy
How We Create Value
Targeted Acquisitions & Development
We focus on acquiring and developing high-impact plasma collection infrastructure — including donor centers, supporting technologies, and real estate — to strengthen the plasma supply chain.
Strategic & Operational Partnership
Beyond capital, we bring hands-on support through operational expertise, strategic oversight, and deep industry knowledge to scale and optimize our platform companies.
Long-Term Platform Building
We’re not just investing in companies — we’re building a sustainable, integrated platform to advance the future of plasma-based healthcare.
OUR TEAM
Meet the Alpha-1 Team
Our leadership team brings decades of investment experience across real estate and health care.
Let’s Start a Conversation
Whether you’re an investor, industry partner, or experienced operator, we welcome the opportunity to connect. Reach out to learn how Alpha-1 Plasma Holdings is building the future of plasma infrastructure — and how you can be a part of it.